Supplementary Tables from RAS–MAPK Pathway-Driven Tumor Progression Is Associated with Loss of CIC and Other Genomic Aberrations in Neuroblastoma

Supplementary Table 1: Public datasets used in this study, Supplementary Table 2: gRNA sequences against CIC, NF1 and DMD, Supplementary Table 3: Primers used for RT-qPCR experiments, Supplementary Table 4: Genes differentially expressed in the various model systems, Supplementary Table 5: Enrichment analysis of Hallmark gene sets , Supplementary Table 6: Statistical analysis of the role of RAS-MAPK activation in survival, Supplementary Table 7: Known RAS-MAPK activating mutations in our tumor series